Mechanisms for the Enhancement of Fracture Healing in Rats Treated With Intermittent Low-Dose Human Parathyroid Hormone (1–34)
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Recent reports have demonstrated that intermittent treatment with parathyroid hormone (1–34) [PTH(1–34)] increases callus formation and mechanical strength in experimental fracture healing. However, little is known about the optimal dose required for enhancement of fracture repair or the molecular mechanisms by which PTH regulates the healing process. In this study, we analyzed the underlying molecular mechanisms by which PTH affects fracture healing and tested the hypothesis that intermittent low-dose treatment with human PTH(1–34) can increase callus formation and mechanical strength. Unilateral femoral fractures were produced and a daily subcutaneous injection of 10 μg/kg of PTH(1–34) was administered during the entire healing period. Control animals were injected with vehicle solution alone. The results showed that on day 28 and day 42 after fracture, bone mineral content (BMC), bone mineral density (BMD), and ultimate load to failure of the calluses were significantly increased in the PTH-treated group compared with controls (day 28, 61, 46, and 32%; day 42, 119, 74, and 55%, respectively). The number of proliferating cell nuclear antigen (PCNA)-positive subperiosteal osteoprogenitor cells was significantly increased in the calluses of the PTH-treated group on day 2, and TRAP+ multinucleated cells were significantly increased in areas of callus cancellous bone on day 7. The levels of expression of type I collagen (COL1A1), osteonectin (ON), ALP, and osteocalcin (OC) mRNA were increased markedly in the PTH-treated group and accompanied by enhanced expression of insulin-like growth factor (IGF)-I mRNA during the early stages of healing (days 4–7). The increased expression of COL1A1, ON, ALP, and OC mRNA continued during the later stages of healing (days 14–21) despite a lack of up-regulation of IGF-I mRNA. These results suggest that treatment of fractures with intermittent low dose PTH(1–34) enhances callus formation by the early stimulation of proliferation and differentiation of osteoprogenitor cells, increases production of bone matrix proteins, and enhances osteoclastogenesis during the phase of callus remodeling. The resultant effect to increase callus mechanical strength supports the concept that clinical investigations on the ability of injectable low-dose PTH(1–34) to enhance fracture healing are indicated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neer, R. M., Arnaud, C. D., Zanchetta, J. R., Prince, R., Gaich, G. A., Reginster, J.-Y., Hodsman, A. B., Eriksen, E. F., Ish-Shalom, S., Genant, H. K., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105103441904 · Cited by 4,602
Bone acid phosphatase: Tartrate-resistant acid phosphatase as a marker of osteoclast function
Minkin, C. (1982) · Calcified Tissue International · doi:10.1007/bf02411252 · Cited by 990
Production of a standard closed fracture in laboratory animal bone
Bonnarens, F., & Einhorn, T. A. (1984) · Journal of Orthopaedic Research · doi:10.1002/jor.1100020115 · Cited by 888
Self-citationKon, T., Cho, T.-J., Aizawa, T., Yamazaki, M., Nooh, N., Graves, D., Gerstenfeld, L. C., & Einhorn, T. A. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.6.1004 · Cited by 552 · cited 9×
“In this study, we analyzed the underlying molecular mechanisms by which PTH affects fracture healing and tested the hypothesis that intermittent low-dose treatment with human PTH(1-34) can increase callus formation and mechanical strength.”
BackgroundMethodResultInfluentialSelf-citationCanalis, E., Centrella, M., Burch, W., & McCarthy, T. L. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113885 · Cited by 543
Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor.
Blair, R. J., Meng, H., Marchese, M. J., Ren, S., Schwartz, L. B., Tonnesen, M. G., & Gruber, B. L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119458 · Cited by 439
Ishizuya, T., Yokose, S., Hori, M., Noda, T., Suda, T., Yoshiki, S., & Yamaguchi, A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119491 · Cited by 349
Andreassen, T. T., Ejersted, C., & Oxlund, H. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.6.960 · Cited by 346
Human Parathyroid Hormone-(l–34) Increases Bone Mass in Ovariectomized and Orchidectomized Rats*
HOCK, J. M., GERA, I., FONSECA, J., & RAISZ, L. G. (1988) · Endocrinology · doi:10.1210/endo-122-6-2899 · Cited by 240
Nakamura, T., Hara, Y., Tagawa, M., Tamura, M., Yuge, T., Fukuda, H., & Nigi, H. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.6.942 · Cited by 213
Owen, T. A., Bortell, R., Yocum, S. A., Smock, S. L., Zhang, M., Abate, C., Shalhoub, V, Aronin, N., Wright, K. L., & van Wijnen, A. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.24.9990 · Cited by 204
Watson, P., Lazowski, D., Han, V., Fraher, L., Steer, B., & Hodsman, A. (1995) · Bone · doi:10.1016/8756-3282(94)00051-4 · Cited by 168
Evidence That Anabolic Effects of PTH on Bone Require IGF-I in Growing Mice
Miyakoshi, N. (2001) · Endocrinology · doi:10.1210/en.142.10.4349 · Cited by 155
Parathyroid Hormone Enhances Fracture Healing: A Preliminary Report
Holzer, G., Majeska, R. J., Lundy, M. W., Hartke, J. R., & Einhorn, T. A. (1999) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199909000-00033 · Cited by 142
Self-citationPreexisting bone loss associated with ovariectomy in rats is reversed by parathyroid hormone
Liu, C. C., Kalu, D. N., Salerno, E., Echon, R., Hollis, B. W., & Ray, M. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650061008 · Cited by 114
Iwaki, A., Jingushi, S., Oda, Y., Izumi, T., Shida, J., Tsuneyoshi, M., & Sugioka, Y. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.1.96 · Cited by 113
Thiede, M. A., Yoon, K., Golub, I. E., Noda, M., & Rodan, G. A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.2.319 · Cited by 105
Reinecke, M., Schmid, A. C., Heyberger-Meyer, B., Hunziker, E. B., & Zapf, J. (2000) · Endocrinology · doi:10.1210/endo.141.8.7624 · Cited by 96
Thomas, M. J., Umayahara, Y., Shu, H., Rotwein, P. S., & McCarthy, T. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.36.21835 · Cited by 82
Nakajima, F., Ogasawara, A., Goto, K., Moriya, H., Ninomiya, Y., Einhorn, T. A., & Yamazaki, M. (2001) · Journal of Orthopaedic Research® · doi:10.1016/s0736-0266(01)00024-9 · Cited by 81
Self-citationSpatial and temporal distribution of CD44 and osteopontin in fracture callus
Yamazaki, M., Nakajima, F., Ogasawara, A., Moriya, H., Majeska, R. J., & Einhorn, T. A. (1999) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.81b3.0810508 · Cited by 75
Self-citationAnabolic effect of high doses of human parathyroid hormone (1–38) in mature intact female rats
Jerome, C. P. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090619 · Cited by 55
Nakajima, A., Nakajima, F., Shimizu, S., Ogasawara, A., Wanaka, A., Moriya, H., Einhorn, T. A., & Yamazaki, M. (2001) · Bone · doi:10.1016/s8756-3282(01)00604-4 · Cited by 44
Self-citationYamazaki, M., Majeska, R. J., Yoshioka, H., Moriya, H., & Einhorn, T. A. (1997) · Journal of Orthopaedic Research® · doi:10.1002/jor.1100150519 · Cited by 38
Self-citationWhitfield, J. F., Morley, P., Ross, V., Isaacs, R., & Rixon, R. H. (1995) · Calcified Tissue International · doi:10.1007/bf00298615 · Cited by 33
Cited by
Current concepts of molecular aspects of bone healing
Dimitriou, R., Tsiridis, E., & Giannoudis, P. V. (2005) · Injury · doi:10.1016/j.injury.2005.07.019 · Cited by 945
Aspenberg, P., Genant, H. K., Johansson, T., Nino, A. J., See, K., Krohn, K., García-Hernández, P. A., Recknor, C. P., Einhorn, T. A., Dalsky, G. P., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090731 · Cited by 513
Self-citationThe roles of signaling pathways in bone repair and regeneration
Majidinia, M., Sadeghpour, A., & Yousefi, B. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26042 · Cited by 513
Modulation of the Inflammatory Response for Enhanced Bone Tissue Regeneration
Mountziaris, P. M., & Mikos, A. G. (2008) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2008.0038 · Cited by 483
ALKHIARY, Y. M., GERSTENFELD, L. C., KRALL, E., WESTMORE, M., SATO, M., MITLAK, B. H., & EINHORN, T. A. (2005) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200504000-00006 · Cited by 308
Self-citation
Metadata
- Authors
- Nakajima, A., Shimoji, N., Shiomi, K., Shimizu, S., Moriya, H., Einhorn, T. A., & Yamazaki, M.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-11-01
- Volume
- 17
- Issue
- 11
- Pages
- 2038-2047
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2092369211
- Cited by
- 274
- References
- 25
- FWCI
- 5.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.